Literature DB >> 22527641

[Benefits and disadvantages of therapy for fibromyalgia syndrome: new insights and decision aids from consumer reports?].

F Petzke.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22527641     DOI： 10.1007/s00482-012-1162-4

Source DB:  PubMed          Journal:  Schmerz        ISSN： 0932-433X            Impact factor:   1.107


× No keyword cloud information.
  3 in total

1.  [Treatment and healthcare costs of fibromyalgia syndrome in Germany: analysis of the data of the Barmer health insurance (BEK) from 2008-2009].

Authors:  U Marschall; B Arnold; W Häuser
Journal:  Schmerz       Date:  2011-08       Impact factor: 1.107

2.  [German fibromyalgia consumer reports. Benefits and harms of fibromyalgia syndrome therapies].

Authors:  W Häuser; E Jung; B Erbslöh-Möller; M Gesmann; H Kühn-Becker; F Petermann; J Langhorst; T Weiss; R Thoma; A Winkelmann
Journal:  Schmerz       Date:  2012-04       Impact factor: 1.107

Review 3.  How well do randomized trials inform decision making: systematic review using comparative effectiveness research measures on acupuncture for back pain.

Authors:  Claudia M Witt; Eric Manheimer; Richard Hammerschlag; Rainer Lüdtke; Lixing Lao; Sean R Tunis; Brian M Berman
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.